This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
B-cell lymphoma protein
From Proteopedia
| Line 2: | Line 2: | ||
[[Image:Bcl-2_3D.jpg|left|200px]] | [[Image:Bcl-2_3D.jpg|left|200px]] | ||
| - | '''B-cell lymphoma proteins''' (Bcl) family are pro-survival proteins. '''Bcl-xL''' (Bcl-2-like protein 1) known as survival protein is the regulator of apoptosis. '''Mcl-1''' is an induced myeloid cell leukemia differentiation protein. '''Bcl-2- | + | '''B-cell lymphoma proteins''' (Bcl) family are pro-survival proteins. '''Bcl-2''' and '''Bcl-xL''' suppress cell death and '''Bak''' and '''Bax''' promote apoptosis.'''Bcl-xL''' (Bcl-2-like protein 1) known as survival protein is the regulator of apoptosis. '''Mcl-1''' is an '''induced myeloid cell leukemia differentiation protein'''. '''Bcl-2-like-7''' is called '''Bak''' for '''Bcl-2 homologous antagonist/killer'''. '''Bcl-2-like-4''' is called '''Bax'''. '''Bcl-2-like-11''' is called '''Bim'''. '''BH3 domain''' is a Bcl-2 homology 3 domain present in Bcl-2 protein family. |
{{Clear}} | {{Clear}} | ||
| Line 38: | Line 38: | ||
{{#tree:id=OrganizedByTopic|openlevels=0| | {{#tree:id=OrganizedByTopic|openlevels=0| | ||
| - | *Bcl-xL | + | *Bcl-xL (Bcl-2-like protein 1) |
| - | **[[1maz]], [[1r2d]], [[2b48]] – hBcl-xL – human<br /> | + | **[[1maz]], [[1r2d]], [[2b48]], [[4ppi]] – hBcl-xL – human<br /> |
**[[1r2e]], [[1r2g]], [[1r2h]], [[1r2i]], [[3cva]] - hBcl-xL (mutant)<br /> | **[[1r2e]], [[1r2g]], [[1r2h]], [[1r2i]], [[3cva]] - hBcl-xL (mutant)<br /> | ||
| - | **[[1lxl]] - hBcl-xL | + | **[[2lpc]], [[2m03]], [[2me8]], [[2me9]], [[1lxl]] - hBcl-xL – NMR<br /> |
| - | **[[ | + | **[[6bf2]] - hBcl-xL (mutant) – NMR<br /> |
| - | + | ||
**[[3fdm]] - hBcl-xL + α/β peptide foldamer<br /> | **[[3fdm]] - hBcl-xL + α/β peptide foldamer<br /> | ||
| + | **[[2mej]] - hBcl-xL + p53 - NMR<br /> | ||
**[[3inq]] - hBcl-xL (mutant) + inhibitor<br /> | **[[3inq]] - hBcl-xL (mutant) + inhibitor<br /> | ||
| - | **[[1ysg]] | + | **[[1ysg]], [[3sp7]], [[3spf]], [[3wiz]], [[4tuh]], [[3zln]], [[3zk6]], [[3zlo]], [[3zlr]], [[4c52]], [[4c5d]], [[2yxj]], [[4qnq]], [[4qvx]] - hBcl-xL + inhibitor<br /> |
| - | + | ||
**[[2w3l]] – hBcl-xL + quinoline derivative<br /> | **[[2w3l]] – hBcl-xL + quinoline derivative<br /> | ||
| - | **[[2o1y]], [[2o2m]], [[2o2n]], [[1ysi]], [[1ysn]] - hBcl-xL + sulfonamide derivative – NMR<br /> | + | **[[2o1y]], [[2o2m]], [[2o2n]], [[1ysi]], [[1ysn]], [[2o21]], [[2o22]], [[2o2f]] - hBcl-xL + sulfonamide derivative – NMR<br /> |
| - | **[[3qkd]] | + | **[[3qkd]], [[4ehr]] - hBcl-xL + sulfonamide derivative<br /> |
| - | + | **[[2pon]] - hBcl-xL + Beclin-1- NMR<br /> | |
| - | **[[2pon]] - hBcl-xL + Beclin-1<br /> | + | |
**[[2p1l]] - hBcl-xL (mutant) + Beclin-1<br /> | **[[2p1l]] - hBcl-xL (mutant) + Beclin-1<br /> | ||
| - | **[[1g5j]] - hBcl-xL residues 1-209 + BAD peptide (mutant)<br /> | ||
**[[3ihc]], [[3iih]], [[1pq0]] – mBcl-xL residues 1-196 – mouse<br /> | **[[3ihc]], [[3iih]], [[1pq0]] – mBcl-xL residues 1-196 – mouse<br /> | ||
| - | **[[3ihd]], [[3ihe]], [[3ihf]], [[3iig]], [[3ilb]], [[3ilc]] - mBcl-xL residues 1-196 (mutant)<br /> | + | **[[3ihd]], [[3ihe]], [[3ihf]], [[3iig]], [[3ilb]], [[3ilc]] - mBcl-xL residues 1-196 (mutant) <br /> |
**[[2bzw]] - mBcl-xL residues 1-211 + BAD<br /> | **[[2bzw]] - mBcl-xL residues 1-211 + BAD<br /> | ||
| - | **[[1pq1]] - mBcl-xL residues 1-196 + | + | **[[1pq1]], [[5c3g]] - mBcl-xL residues 1-196 + BIM peptide<br /> |
**[[1af3]] - rBcl-xL soluble domain<br /> | **[[1af3]] - rBcl-xL soluble domain<br /> | ||
| - | **[[1bxl]] - Bcl-xL + Bak peptide – | + | **[[1bxl]] - Bcl-xL + Bak peptide – Escherichia coli – NMR<br /> |
| + | **[[5twa]] - Bcl-xL + Bak peptide – sponge<br /> | ||
| + | |||
| + | *Bcl-xL complex with BH3 domain peptide | ||
| + | |||
| + | **[[3pl7]] - hBcl-xL (mutant) + apoptosis regulator BAX BH3 domain<br /> | ||
| + | **[[5fmk]], [[5fmj]] - hBcl-xL + Bak BH3 domain<br /> | ||
| + | **[[4qve]] - hBcl-xL + BID BH3 domain<br /> | ||
| + | **[[1g5j]] - hBcl-xL + BAD BH3 peptide <br /> | ||
| + | **[[5b1z]] - hBcl-xL + BHX BH3 domain<br /> | ||
| + | **[[4z9v]] - hBcl-xL + TCTP BH3 domain<br /> | ||
| + | **[[2yq6]], [[4qvf]], [[4yk9]], [[3fdl]], [[5agx]], [[4yj4]], [[3io8]], [[2yq7]], [[5vx3]], [[5agw]] - hBcl-xL + BIM BH3 domain<br /> | ||
| + | **[[2yj1]], [[4bpk]], [[4hnj]] - hBcl-xL + α/β-Puma BH3 domain<br /> | ||
| + | **[[4a1u]], [[4a1w]] - hBcl-xL + α/β-foldamer BH3 domain<br /> | ||
| + | **[[3r85]] - hBcl-xL + heme-binding protein BH3 peptide<br /> | ||
| + | **[[2lp8]] – hBcl-xL + Bcl-2 homologous antagonist/killer BH3 peptide - NMR<br /> | ||
| + | **[[2m04]] – hBcl-xL (mutant) + Bcl-2 binding component 3 BH3 peptide - NMR<br /> | ||
| + | **[[5wos]] - Bcl-xL + hBIM BH3 domain – canarypox virus<br /> | ||
| + | **[[5tzp]] - fpvBcl-xL + BIK BH3 domain – fowlpox virus<br /> | ||
| + | **[[5tzq]] - fpvBcl-xL + Bmf BH3 domain <br /> | ||
*Bcl-2 | *Bcl-2 | ||
| - | **[[1gjh | + | **[[1gjh, [[1g5m]] – hBcl-2<br /> |
| - | **[[4aq3]], [[4man]], [[5jsn]] – hBcl-2 + inhibitor<br /> | + | **[[4aq3]], [[4man]], [[5jsn]], [[4ieh]] – hBcl-2 + inhibitor<br /> |
**[[4lvt]], [[4lxd]] – hBcl-2 (mutant) + inhibitor<br /> | **[[4lvt]], [[4lxd]] – hBcl-2 (mutant) + inhibitor<br /> | ||
| - | **[[5fcg]] – hBcl-2 (mutant) + HBX | + | **[[5fcg]] – hBcl-2 (mutant) + HBX BH3 domain<br /> |
| - | **[[2xa0]] – hBcl-2 residues 1-207 + apoptosis regulator | + | **[[2xa0]] – hBcl-2 residues 1-207 + apoptosis regulator Bax BH3 domain<br /> |
| - | **[[2o21]], [[2o22]], [[2o2f]], [[1ysw]] - hBcl-2 + sulfonamide derivative - NMR<br /> | + | **[[2o21]], [[2o22]], [[2o2f]], [[1ysw]] - hBcl-2 + sulfonamide derivative – NMR |
| + | |||
| + | *Bcl-2-related protein A1 (Bfl-1) | ||
| + | |||
| + | **[[5whi]] - hBcl-2A1 (mutant) <br /> | ||
| + | **[[2vm6]] – hBcl-2A1 + hBIM BH3 peptide<br /> | ||
| + | **[[2vof]] - mBcl-2A1 + Bcl-2 binding component 3 BH3 peptide <br /> | ||
| + | **[[2vog]] - mBcl-2A1 + Bmf BH3 peptide <br /> | ||
| + | **[[2voh]] - mBcl-2A1 + Bak BH3 peptide <br /> | ||
| + | **[[2voi]] - mBcl-2A1 + BID BH3 peptide <br /> | ||
| + | **[[3mqp]] - hBcl-2A1 + Noxa BH3 peptide <br /> | ||
| + | **[[5uul]] - hBcl-2A1 + PUMA BH3 peptide <br /> | ||
| + | **[[5uuk]], [[5uup]] - hBcl-2A1 + Bfl-1 peptide <br /> | ||
| + | **[[4zeq]] - hBcl-2A1 + BID BH3 peptide <br /> | ||
| + | |||
| + | *Bcl-3 | ||
| + | |||
| + | **[[1k1a]], [[1k1b]] – hBcl-3 ankyrin repeat domain <br /> | ||
| + | |||
| + | *Bcl-6 | ||
| + | |||
| + | **[[3e4u]], [[1r28]], [[1r29]], [[4u2m]] – hBcl-6 BTB domain <br /> | ||
| + | **[[3lbz]], [[5mw6]], [[5mw2]], [[5mwd]], [[5n1x]], [[5n1z]], [[5n20]], [[5n21]], [[5x4m]], [[5x4n]], [[5x4o]], [[5x4p]], [[5x9o]], [[5x9p]], [[5x4o]] – hBcl-6 BTB domain + inhibitor<br /> | ||
| + | **[[4cp3]] – hBcl-6 BTB domain + antibiotic<br /> | ||
| + | **[[3bim]] – hBcl-6 BTB domain (mutant) + Bcl-6 corepressor<br /> | ||
| + | **[[5h7g]], [[5h7h]] – hBcl-6 BTB domain + F1324 peptide<br /> | ||
| + | **[[1r2b]] – hBcl-6 BTB domain + SMRT peptide<br /> | ||
| + | **[[2lce]] – hBcl-6 zinc fingers 2-3 - NMR<br /> | ||
| + | |||
| + | *Bcl-9 | ||
| + | |||
| + | **[[3sl9]] – hBcl-9 residues 344-396 + catenin beta-1<br /> | ||
| + | |||
| + | *Bcl-10 | ||
| + | |||
| + | **[[2mb9]] – hBcl-10 CARD domain (mutant) – NMR<br /> | ||
| + | **[[6bze]] – hBcl-10 CARD domain – Cryo EM<br /> | ||
| + | |||
| + | *Bcl-W (Bcl-2-like protein 2) | ||
| + | |||
| + | **[[1o0l]], [[1mk3]], [[2y6w]] – hBcl-W (mutant) <br /> | ||
| + | **[[1zy3]], [[4cim]] - hBcl-W (mutant) + BID BH3 peptide<br /> | ||
| + | **[[4k5a]], [[4k5b]] - Bcl-W (mutant) + ankyrin repeat - bovine<br /> | ||
| + | **[[4cin]] - hBcl-W + BH3 peptide<br /> | ||
| + | |||
| + | *Bcl-2-like protein 4 (Bax) | ||
| + | |||
| + | **[[4bd7]], [[4s0o]], [[4s0p]] - hBax <br /> | ||
| + | **[[4bd8]] – hBax (mutant) <br /> | ||
| + | **[[2lr1]] - hBax + VMIA peptide<br /> | ||
| + | **[[4bd6]] – hBax (mutant) + BH3 peptide<br /> | ||
| + | **[[2k7w]] – hBax + BIM BH3 peptide - NMR<br /> | ||
| + | **[[4zie]], [[4zif]], [[4zig]], [[4zih]], [[4zii]], [[5vww]] – hBax (mutant) + BIM BH3 peptide<br /> | ||
| + | **[[4bd2]] – hBax (mutant) + BID BH3 peptide<br /> | ||
| + | |||
| + | *Bcl-2-like protein 5 | ||
| + | |||
| + | **[[3i1h]] - hBcl-2-L-5 + hBak<br /> | ||
| + | |||
| + | *Bcl-2-like protein 7 (Bak, Bcl-2 homologous antagonist/killer) | ||
| + | |||
| + | **[[2yv6]], 2imt, 2jcn, 2ims – hBak<br /> | ||
| + | **[[5fmi]], [[4u2u]], [[5vx1]] – hBak (mutant)<br /> | ||
| + | **[[4u2v]] – hBak/GFP<br /> | ||
| + | **[[3qbr]] - hBak + sjA<br /> | ||
| + | **[[2xpx]] - hBak fragment + BHRF1<br /> | ||
| + | **[[5vwx]], [[5vwy]], [[5vwz]], [[5vx0]] - hBak + BIM BH3 domain<br /> | ||
| + | **[[5vwv]] - hBak (mutant)+ BIM BH3 domain<br /> | ||
| + | **[[2m5b]] - hBak + BID BH3 domain - NMR<br /> | ||
| + | |||
| + | *Bcl-2-like protein 10 | ||
| + | |||
**[[2kua]] – mBcl-2-L-10<br /> | **[[2kua]] – mBcl-2-L-10<br /> | ||
| - | **[[ | + | **[[4b4s]] - hBcl-2-L-10 + hBIM BH3 peptide<br /> |
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | *Bcl- | + | *Bcl-2-like protein 11 (BIM) |
| - | **[[ | + | **[[2nl9]] – hBIM + Mcl-1<br /> |
| - | + | ||
| - | + | Mcl-1 (Bcl-2-like protein 3) | |
| - | + | **[[1wsx]] – mMcl-1 residues 152-308 - NMR<br /> | |
| - | **[[1wsx]] – mMcl-1 residues 152-308 | + | |
| - | + | ||
| - | + | ||
| - | + | ||
**[[3mk8]] - hMcl-1 fragment<br /> | **[[3mk8]] - hMcl-1 fragment<br /> | ||
**[[2mhs]] - hMcl-1 fragment (mutant)<br /> | **[[2mhs]] - hMcl-1 fragment (mutant)<br /> | ||
| - | **[[3pk1]] – hMcl-1 fragment + hBcl-2-L-4 BH3 domain<br /> | ||
| - | **[[3kj0]], [[3kj1]], [[3kj2]], [[3io9]] - hMcl-1 fragment + hBcl-2-L-11 BH3 domain (mutant)<br /> | ||
| - | **[[3d7v]], [[2pqk]] - hMcl-1 fragment + hBcl-2-L-11 BIM BH3<br /> | ||
| - | **[[2kbw]] - hMcl-1 fragment + BID BH3 peptide – NMR<br /> | ||
**[[4wms]] - hMcl-1/MBP (mutant) <br /> | **[[4wms]] - hMcl-1/MBP (mutant) <br /> | ||
**[[5lof]] - hMcl-1/MBP + inhibitor<br /> | **[[5lof]] - hMcl-1/MBP + inhibitor<br /> | ||
| Line 103: | Line 175: | ||
**[[4wmu]], [[4wmt]] - hMcl-1/MBP (mutant) + ligand<br /> | **[[4wmu]], [[4wmt]] - hMcl-1/MBP (mutant) + ligand<br /> | ||
**[[4wgi]] - hMcl-1/MBP (mutant) + macrolactam<br /> | **[[4wgi]] - hMcl-1/MBP (mutant) + macrolactam<br /> | ||
| - | + | [[3wix]], [[3wiy]], [[4oq5]], [[4oq6]], [[4hw2]], [[4hw3]], [[4hw4]], [[4wmr]], [[4zbf]], [[4zbi]], [[5fc4]], [[5fdo]], [[5fdr]], [[5iez]], [[5if4]], [[5jsb]], [[5ku9]], [[5vkc]], [[6b4l]], [[6b4u]], [[6bw2]], [[6bw8]] - hMcl-1 fragment + inhibitor<br /> | |
| - | **[[4bpj]] - hMcl-1 fragment + BH3 peptide <br /> | + | **[[5uum]] - hMcl-1 fragment + FS2 peptide <br /> |
| + | **[[5c3f]] - hMcl-1 fragment + BIB MM <br /> | ||
| + | **[[5mes]], [[5mev]] - hMcl-1 fragment + inhibitor + antibody<br /> | ||
| + | |||
| + | *Mcl-1 complex with BH3 domain peptide | ||
| + | |||
| + | **[[2nla]], [[4g35]] – rMcl-1 fragment + NoxaB BH3 domain<br /> | ||
| + | **[[2jm6]], [[2rod]] – mMcl-1 fragment + NoxaB fragment – NMR<br /> | ||
| + | **[[2roc]] - mMcl-1 fragment + Puma BH3 domain<br /> | ||
| + | **[[3kz0]] - hMcl-1 + MB7 BH3 domain<br /> | ||
| + | **[[3pk1]] – hMcl-1 fragment + hBax BH3 domain<br /> | ||
| + | **[[2kbw]] - hMcl-1 fragment + BID BH3 peptide – NMR<br /> | ||
| + | **[[4bpj]], [[4bpi]] - hMcl-1 fragment + Puma BH3 peptide <br /> | ||
| + | **[[5c6h]] - hMcl-1 fragment + Mule BH3 peptide <br /> | ||
| + | **[[5w89]], [[5w8f]], 3kj0, 3kj1, 3kj2, 3io9, 3d7v, 2pqk, [[5vx2]] - hMcl-1 fragment + BIM BH3 peptide <br /> | ||
| + | **[[2kbw]] - hMcl-1 fragment + BID BH3 peptide - NMR <br /> | ||
*M11 | *M11 | ||
**[[2o42]], [[2jbx]] – MvM11L – Myxoma virus<br /> | **[[2o42]], [[2jbx]] – MvM11L – Myxoma virus<br /> | ||
| - | **[[2jby]] – MvM11L + Bcl-2 homologous | + | **[[2jby]] – MvM11L + Bcl-2 homologous antagonist/killer <br /> |
| - | **[[3dvu]], [[3bl2]] – M11 + Beclin-1 – Murid herpesvirus<br /> | + | **[[3dvu]], [[3bl2]], [[4mi8]] – M11 + Beclin-1 – Murid herpesvirus<br /> |
| - | + | N1L | |
**[[2i39]] – VvN1L – Vaccinia virus<br /> | **[[2i39]] – VvN1L – Vaccinia virus<br /> | ||
**[[4bbb]], [[4bbc]], [[4bbd]] – VvN1L (mutant)<br /> | **[[4bbb]], [[4bbc]], [[4bbd]] – VvN1L (mutant)<br /> | ||
| - | + | }} | |
| + | |||
==References== | ==References== | ||
Revision as of 10:03, 27 February 2018
| |||||||||||
3D structures of Bcl-2
Updated on 27-February-2018 {{#tree:id=OrganizedByTopic|openlevels=0|
- Bcl-xL (Bcl-2-like protein 1)
- 1maz, 1r2d, 2b48, 4ppi – hBcl-xL – human
- 1r2e, 1r2g, 1r2h, 1r2i, 3cva - hBcl-xL (mutant)
- 2lpc, 2m03, 2me8, 2me9, 1lxl - hBcl-xL – NMR
- 6bf2 - hBcl-xL (mutant) – NMR
- 3fdm - hBcl-xL + α/β peptide foldamer
- 2mej - hBcl-xL + p53 - NMR
- 3inq - hBcl-xL (mutant) + inhibitor
- 1ysg, 3sp7, 3spf, 3wiz, 4tuh, 3zln, 3zk6, 3zlo, 3zlr, 4c52, 4c5d, 2yxj, 4qnq, 4qvx - hBcl-xL + inhibitor
- 2w3l – hBcl-xL + quinoline derivative
- 2o1y, 2o2m, 2o2n, 1ysi, 1ysn, 2o21, 2o22, 2o2f - hBcl-xL + sulfonamide derivative – NMR
- 3qkd, 4ehr - hBcl-xL + sulfonamide derivative
- 2pon - hBcl-xL + Beclin-1- NMR
- 2p1l - hBcl-xL (mutant) + Beclin-1
- 3ihc, 3iih, 1pq0 – mBcl-xL residues 1-196 – mouse
- 3ihd, 3ihe, 3ihf, 3iig, 3ilb, 3ilc - mBcl-xL residues 1-196 (mutant)
- 2bzw - mBcl-xL residues 1-211 + BAD
- 1pq1, 5c3g - mBcl-xL residues 1-196 + BIM peptide
- 1af3 - rBcl-xL soluble domain
- 1bxl - Bcl-xL + Bak peptide – Escherichia coli – NMR
- 5twa - Bcl-xL + Bak peptide – sponge
- 1maz, 1r2d, 2b48, 4ppi – hBcl-xL – human
- Bcl-xL complex with BH3 domain peptide
- 3pl7 - hBcl-xL (mutant) + apoptosis regulator BAX BH3 domain
- 5fmk, 5fmj - hBcl-xL + Bak BH3 domain
- 4qve - hBcl-xL + BID BH3 domain
- 1g5j - hBcl-xL + BAD BH3 peptide
- 5b1z - hBcl-xL + BHX BH3 domain
- 4z9v - hBcl-xL + TCTP BH3 domain
- 2yq6, 4qvf, 4yk9, 3fdl, 5agx, 4yj4, 3io8, 2yq7, 5vx3, 5agw - hBcl-xL + BIM BH3 domain
- 2yj1, 4bpk, 4hnj - hBcl-xL + α/β-Puma BH3 domain
- 4a1u, 4a1w - hBcl-xL + α/β-foldamer BH3 domain
- 3r85 - hBcl-xL + heme-binding protein BH3 peptide
- 2lp8 – hBcl-xL + Bcl-2 homologous antagonist/killer BH3 peptide - NMR
- 2m04 – hBcl-xL (mutant) + Bcl-2 binding component 3 BH3 peptide - NMR
- 5wos - Bcl-xL + hBIM BH3 domain – canarypox virus
- 5tzp - fpvBcl-xL + BIK BH3 domain – fowlpox virus
- 5tzq - fpvBcl-xL + Bmf BH3 domain
- 3pl7 - hBcl-xL (mutant) + apoptosis regulator BAX BH3 domain
- Bcl-2
- Bcl-2-related protein A1 (Bfl-1)
- 5whi - hBcl-2A1 (mutant)
- 2vm6 – hBcl-2A1 + hBIM BH3 peptide
- 2vof - mBcl-2A1 + Bcl-2 binding component 3 BH3 peptide
- 2vog - mBcl-2A1 + Bmf BH3 peptide
- 2voh - mBcl-2A1 + Bak BH3 peptide
- 2voi - mBcl-2A1 + BID BH3 peptide
- 3mqp - hBcl-2A1 + Noxa BH3 peptide
- 5uul - hBcl-2A1 + PUMA BH3 peptide
- 5uuk, 5uup - hBcl-2A1 + Bfl-1 peptide
- 4zeq - hBcl-2A1 + BID BH3 peptide
- 5whi - hBcl-2A1 (mutant)
- Bcl-3
- Bcl-6
- 3e4u, 1r28, 1r29, 4u2m – hBcl-6 BTB domain
- 3lbz, 5mw6, 5mw2, 5mwd, 5n1x, 5n1z, 5n20, 5n21, 5x4m, 5x4n, 5x4o, 5x4p, 5x9o, 5x9p, 5x4o – hBcl-6 BTB domain + inhibitor
- 4cp3 – hBcl-6 BTB domain + antibiotic
- 3bim – hBcl-6 BTB domain (mutant) + Bcl-6 corepressor
- 5h7g, 5h7h – hBcl-6 BTB domain + F1324 peptide
- 1r2b – hBcl-6 BTB domain + SMRT peptide
- 2lce – hBcl-6 zinc fingers 2-3 - NMR
- 3e4u, 1r28, 1r29, 4u2m – hBcl-6 BTB domain
- Bcl-9
- 3sl9 – hBcl-9 residues 344-396 + catenin beta-1
- 3sl9 – hBcl-9 residues 344-396 + catenin beta-1
- Bcl-10
- Bcl-W (Bcl-2-like protein 2)
- Bcl-2-like protein 4 (Bax)
- Bcl-2-like protein 5
- 3i1h - hBcl-2-L-5 + hBak
- 3i1h - hBcl-2-L-5 + hBak
- Bcl-2-like protein 7 (Bak, Bcl-2 homologous antagonist/killer)
- Bcl-2-like protein 10
- Bcl-2-like protein 11 (BIM)
- 2nl9 – hBIM + Mcl-1
- 2nl9 – hBIM + Mcl-1
Mcl-1 (Bcl-2-like protein 3)
3wix, 3wiy, 4oq5, 4oq6, 4hw2, 4hw3, 4hw4, 4wmr, 4zbf, 4zbi, 5fc4, 5fdo, 5fdr, 5iez, 5if4, 5jsb, 5ku9, 5vkc, 6b4l, 6b4u, 6bw2, 6bw8 - hMcl-1 fragment + inhibitor
- Mcl-1 complex with BH3 domain peptide
- 2nla, 4g35 – rMcl-1 fragment + NoxaB BH3 domain
- 2jm6, 2rod – mMcl-1 fragment + NoxaB fragment – NMR
- 2roc - mMcl-1 fragment + Puma BH3 domain
- 3kz0 - hMcl-1 + MB7 BH3 domain
- 3pk1 – hMcl-1 fragment + hBax BH3 domain
- 2kbw - hMcl-1 fragment + BID BH3 peptide – NMR
- 4bpj, 4bpi - hMcl-1 fragment + Puma BH3 peptide
- 5c6h - hMcl-1 fragment + Mule BH3 peptide
- 5w89, 5w8f, 3kj0, 3kj1, 3kj2, 3io9, 3d7v, 2pqk, 5vx2 - hMcl-1 fragment + BIM BH3 peptide
- 2kbw - hMcl-1 fragment + BID BH3 peptide - NMR
- 2nla, 4g35 – rMcl-1 fragment + NoxaB BH3 domain
- M11
N1L
}}
References
Proteopedia Page Contributors and Editors (what is this?)
Michal Harel, Colin Ridenour, David Canner, Alexander Berchansky, Jaime Prilusky
Categories: Topic Page | Bcl 2 | Bax | Bok | Bad | Bak | Bcl-xl | Bcl xl | Bcl-w | Bcl w | Apoptosis | Mmp | Mitochondrial membrane permeabilization | B cell lymphoma 2 | Signal transduction

